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ABSTRACT
Phosphorylation of histone H2AX on serine 139
(gamma-H2AX, gH2AX) occurs at sites flanking DNA
double-strand breaks (DSBs) and can provide
a measure of the number of DSBs within a cell.
Here we describe a rapid and simple flow-
cytometry-based method, optimized to measure
gamma-H2AX in non-fixed peripheral blood cells.
No DSB induced signal was observed in H2AX / 
cells indicating that our FACS method specifically
recognized gamma-H2AX accumulation. The
gamma-H2AX assay was capable of detecting DNA
damage at levels 100-fold below the detection limit of
the alkaline comet assay. The gamma-H2AX signal
was quantitative with a linear increase of the gamma-
H2AX signal over two orders of magnitude. We found
that all nucleated blood cell types examined, includ-
ing the short-lived neutrophils induce gamma-H2AX
in response to DSBs. Interindividual difference in the
gamma-H2AX signal in response to ionizing radiation
and the DSB-inducing drug calicheamicin was
almost 2-fold in blood cells from patients, indicating
that the amount of gamma-H2AX produced in
response to a given dose of radiation varies sig-
nificantly in the human population. This simple
method could be used to monitor response to
radiation or DNA-damaging drugs.
INTRODUCTION
Ionizingradiation(IR)andmanychemotherapeuticagents
kill cancercellsbyinductionof DNAdouble-strand breaks
(DSBs) (1). Since both strands are damaged, DSBs
are more diﬃcult to repair compared to base damage or
single-strand DNA breaks (SSBs) that leaves one template
strand intact to guide repair. Therefore, DSBs activate
a distinct signaling system that is capable of detecting
a few, possibly a single DSB (2,3). Activation of the DSB
signal often results in cell death or permanent growth
arrest. Since DSBs are more toxic in fast growing cells,
agents that induce DSBs are often used to treat cancer.
Most DSB inducers also generate large numbers of SSBs,
which likely participate little to the toxic eﬀect (1). In the
caseofIR,thelevelofSSBsis20–40timeshighercompared
to the levels of DSBs. The agent that produces the highest
relative levels of DSBs is the enediyne calicheamicin g1
(CLM).Thisdrugcontainstworadicalcentersthatbecome
positioned close to the opposing strands when it binds the
minor groove of double-stranded DNA. Activation of the
radical centers is cooperative, resulting in eﬃcient cutting
of both DNA strands (4). We have earlier shown that at
least 30% of the CLM-induced strand breaks are DSBs in
cellular DNA (5).
The clinical eﬀects of DSB inducing agents are highly
variable among individuals (6). Therefore, the same dose
of IR can result in severe side eﬀects in some cancer
patients while other patients show no obvious sign of the
delivered dose. It would therefore be advantageous if we
could measure the DNA damage response in each patient
and use this signal to guide the dosing. Previous attempts
to measure DNA damage in patients undergoing
chemotherapy have relied on the alkaline comet assay.
In this assay, individual cells are molded into agarose
on microscopic slides and exposed to an electrical ﬁeld
after alkaline in-gel lysis. The electrical ﬁeld forces cellular
DNA containing strand breaks to migrate from the
nucleus generating a ‘comet tail’ that is proportional to
the level of SSBs and DSBs in the cell (7,8).
An early event after introduction of DSBs is the
phosphorylation of a special form of histone 2A,
denoted H2AX that is part of 10% of all nucleosomes
in the cell (9–11). Histone 2AX contains a distinct
C-terminal extension, with a consensus phosphorylation
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ATM and DNA-PK are responsible for the formation of
several thousands of phosphorylated H2AX (gH2AX,
H2AXS139ph (12) or gamma-H2AX) in a 2-Mbp region
of the DSB, within minutes after its formation (10,13–17).
Gamma-H2AX is speciﬁcally bound by MDC1 that assist
in the assembly of several proteins, including ATM, the
Mre11/Rad50/Nibrin complex and 53BP1 that subse-
quently participates in the spreading of gamma-H2AX
formation in a 2-Mbp region from the DSB (18–20).
This ampliﬁcation of the locally generated DSB signal
later assist in the globalization of the DSB response
through massive ATM-mediated Chk2 activation (21)
(reviewed in (22)). In yeast, the H2AX homolog H2A,
is also phosphorylated in a DSB-dependent manner (23),
and participates in the assembly of chromatin-remodeling
complexes, called SwrC, Ino80 and NuA4. These com-
plexes are required for the modulation of the chromatin
structure that is observed surrounding a DSB and for
normal resistance to IR (24,25). It is likely that the Tip60
complex has a similar chromatin modulating function in
human cells (26). Mouse cells lacking H2AX show defects
in the DSB response and DSB repair, which is especially
pronounced at low levels of DSBs (27). This, and other
lines of evidence, indicates that formation of gamma-
H2AX is required for the proper ampliﬁcation of the
DSB response after low doses of radiation.
The local formation of gamma-H2AX allows micro-
scopical detection of distinct foci by ﬂuorescent
gamma-H2AX-speciﬁc antibodies that most likely repre-
sent a single DSB (28–30). The potential to detect a single
focus within the nucleus makes this the most sensitive
method currently available for detecting DSBs in cells.
This method is, however, labor-intensive and will be
diﬃcult to adapt in clinical practice. In contrast, ﬂow
cytometry allows simple detection of gamma-H2AX in
a large number of cells (31). Several reports show that
the level of gamma-H2AX as detected by ﬂow cytometry
correlates well with the number of DNA strand breaks,
to the level of cell death and radiosensitivity (32–34).
We have developed a ﬂow-cytometry-based method
optimized for measurement of gamma-H2AX in non-
ﬁxed cells. Our assay was apparently speciﬁc for gamma-
H2AX, since no DNA damage induced signal was obtained
in H2AX /  cells. The gamma-H2AX signal was linearly
correlated with the level of DNA damage and detected
hundred times lower levels of CLM-induced DNA damage
compared to the alkaline comet assay. We ﬁnd that all
nucleated blood cells are able to induce gamma-H2AX, but
to diﬀerent levels. There was a signiﬁcant interindividual
diﬀerence in the gamma-H2AX signal at a given DNA
damage level. This ﬂow cytometry method can be used to
measure the level of DSBs in patient cells, for example, in
patients undergoing chemotherapy.
MATERIALS AND METHODS
Drug exposure andpreparation of bloodcells
Calicheamicin g1 (CLM) was a generous gift from
George Ellestad (Wyeth-Ayers Research), dissolved at
2mM in DMSO in small fractions (Sigma), and stored at
 708C. Under these conditions, CLM showed no loss
of activity. Repeated freeze and thaw cycles, especially at
low concentration, was shown to inactivate CLM, and
therefore avoided. The H2AX /  and H2AXþ/þ cells
were a generous gift from Andre Nussenzweig (27). Blood
samples, not older than 3h, were collected from routine
hematology laboratory, after routine full blood count
analysis on a Celldyn cell counter (Abbott). Drugs were
added directly to the blood, and the blood samples were
incubated at 378C under continuous rocking. For incuba-
tion with CLM, it was found that the maximum level
of gamma-H2AX signal was reached after a 30-min of
incubation. After incubation with drugs, the blood
samples were kept on ice during preparation. Total
white blood cells were prepared by mixing 70ml of blood
with 1.6ml of ice-cold lysis solution (0.154M NH4Cl,
0.01M KHCO3, 0.09mM EDTA, pH 7.3) on ice for
20min. After centrifugation at 4000rpm, 4min at 08C, the
cell pellet was resuspended in 1ml of ice-cold lysis solution
for 10–20min, and centrifuged as above. The cell pellet
was suspended in 25ml of PBS (1.9mM NaH2PO4, 8.1mM
Na2HPO4, 154mM NaCl, pH 7.2), supplemented with
1g/l bovine serum albumin (BSA), (fraction V, Sigma)
and stored on ice no longer than 3h before analysis of
gamma-H2AX, or by the comet assay. Lymphocytes were
prepared by carefully pipetting 2ml blood mixed 1:1 in
PBS supplemented with 5mM EDTA on a layer with
1.5ml lymphoprep (AXIS-SHIELD PoC AS) in a 5ml
ﬂow-cytometry tube. Centrifugation at 1200g was for
10min at 08C. The lymphocyte layer was mixed with
1.3ml of lysis solution, incubated for 20min on ice and
centrifuged as described for total white blood cell
preparation (above). Neutrophils were prepared from
the erythrocyte pellet obtained in the lymphoprep by
removing the lymphoprep solution and resuspending the
erythrocyte pellet 1:25 in lysis solution. After incubation
on ice for 20–40min the solution was centrifuged 1200g
for 10min and the pellet resuspended in 1.5ml lysis
solution, incubated for 20min and centrifuged as
described for preparation of total white blood cells.
Puriﬁed lymphocytes were frozen by resuspending the
cells in PBS-Pi (PBS supplemented with 10mM NaF,
1mMNa 2MoO4, 1mM NaVO3) at 1 million cells/ml and
frozen in 10ml fractions at  808C. Upon analysis, 200ml
of Block8 was added directly to the frozen cells and
processed as described below. Manual diﬀerential count of
200 cells after May–Gru ¨ nwald stain showed that the
lymphocyte preparation contained 94% lymphocytes,
6% monocytes and 50.5% neutrophils. The neutrophil
preparation contained 98.5% neutrophils, 1.5% lympho-
cytes and 50.5% monocytes. Fixation with ethanol was
done as described (31). Fixation with paraformaldehyde
(PFA, Sigma) was done by suspending 100000 WBC
in 0.5ml PBS, supplemented with 1% PFA, on ice for
10min. Cells were collected by centrifugation, and washed
twice with 1ml PBS 1g/l BSA. Blood (2.8ml) in 5.2cm
petri dishes were irradiated on ice, with a Philips RT 100
X-ray machine, using an acceleration voltage of 100kV
and 13Gy/min.
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Staining for gamma-H2AX was done by adding
5000–100000 cells to 150–200ml of Block 8 (PBS
supplemented with 1g/l BSA, 8% mouse serum (Sigma),
0.1g/l RNase A type XII-A (Sigma), phosphatase
inhibitors (10mM NaF, 1mM Na2MoO4,1 m M
NaVO3), 0.25g/l sonicated herring-sperm DNA type
XIV (Sigma), 0.1% Triton X100, 0.44mg/l monoclonal
anti-gamma-H2AX, FITC conjugate (Upstate biotechnol-
ogy, 16-202A), 0.02% NaN3). Incubation was for 4–20h
on ice in the dark, before dilution with 350ml PFA
dilution buﬀer (PBS supplemented with 2% PFA).
The samples were analyzed directly on a FACSScan
(Becton & Dickinson), with calibrations done using FITC-
labeled plastic beads (Calibrite, Becton & Dickinson).
Fluorescence intensity in arbitrary units was plotted in
histograms, and the mean ﬂuorescence intensity was
calculated using Weasel version 2.3 software. To check
for doublets, white blood cells (WBC) were prepared from
several patients, and stained with propidium iodide in
Block 8 and analyzed by ﬂow cytometry. These tests
consistently showed that doublet nuclei were50.1%, and
that no S- or G2-phase cells were present.
Flow-cytometry-mediated sorting
WBC were prepared as described above after treatment
with various concentration of CLM and 25 million
cells were stained with anti-CD3 conjugated to activated
peridinin-chlorophyll-protein (PerCP), and anti-CD14
conjugated to phycoerythrin. In a separate tube,
25 millon cells from each CLM treatment were stained
with anti-CD20 conjugated to phycoerythrin (PE),
and anti-CD23 conjugated to allophycocyanin (APC).
All antibodies were from Becton and Dickinson.
The labeled cells were sorted on a FACSAria (Becton
and Dickinson), using settings suggested by the manufac-
turer. Neutrophils were sorted based on light scatter
characteristics, intermediate CD14 expression. Monocytes
were separated based on light scatter characteristics
and strong CD14 expression. T-lymphocytes were selected
based on light scatter characteristics and high CD3
expression. B-lymphocytes were selected based on light
scatter characteristics, strong CD20 and CD23 expression
and absence of CD3 expression. Sorted cells were collected
in PBS, 1g/l BSA. The entire sorting procedure was
done at þ48C in 1h. After sorting, the cells were concen-
trated by centrifugation and prepared for gamma-H2AX
analysis and comet assay.
Comet assay
The comet assay was performed as described previously,
with some modiﬁcations. Brieﬂy, 5000–10000 cells were
mixed with 150ml 0.75% low-melting agarose (Sigma type
VII, USA), kept at 378C. The agarose-cell suspension was
spread onto pre-chilled gel bond ﬁlm (Cambrex Bio
Science Rockland). The preparations were left on a chilled
plate for 5min before lysis (0.03M NaOH, 1M NaCl,
2mM EDTA, 0.5% N-lauryl sarcosine) for 1h, and
thereafter equilibrated (0.03M NaOH, 2mM EDTA)
for 1h. Electrophoresis of the agarose embedded cells
was run at 0.67V/cm for 15min in the same solution.
The ﬁlm was then neutralized in 0.4M Tris-HCl, pH 7.5,
ﬁxed in 99.5% ethanol for 2h, and allowed to dry, usually
overnight. After staining of the ﬁlm with SybrGold
(molecular probes) for 5min, it was rinsed brieﬂy in
de-ionized water. Analysis of the DNA that migrated from
the nuclei was done by visual scoring (35) or measurement
of the percentage of total DNA in the comet tail by Comet
III software (Perceptive Instruments Ltd).
RESULTS
Development of anoptimized protocol forgamma-H2AX
staining inwhite bloodcells
EDTA-blood was treated in vitro with CLM to induce
DSBs. Total white blood cells (WBC) or lymphocytes were
prepared and subjected to diﬀerent ﬁxation protocols, and
stained for gamma-H2AX using a FITC-labeled antibody.
The FITC signal was measured in isolated cells using ﬂow
cytometry. It was found that the gamma-H2AX signal
only increased 2–3-fold in CLM-treated WBC using
published protocols (31). Gamma-H2AX is a nucleosomal
protein, and therefore retained in the nucleus along with
other histones when cells are lysed at physiological salt
concentration. It was therefore reasoned that non-ﬁxed
nuclei could be stained with the FITC-labeled gamma-
H2AX antibody. We tested this by mixing non-ﬁxed,
CLM-treated WBC with the FITC-labeled gamma-H2AX
antibody in a detergent-containing buﬀer. Using this
protocol we observed a 10-fold increase of the gamma-
H2AX signal in CLM-treated WBC (Figure 1A).
This showed that non-ﬁxed cells were eﬃciently stained
with the FITC-labeled gamma-H2AX antibody. In addi-
tion, no gamma-H2AX could be detected in extracts from
CLM-treated cells under these conditions, indicating that
no gamma-H2AX was lost from the nuclei during the
staining procedure (data not shown). We conclude that
it is possible to stain non-ﬁxed cells for gamma-H2AX
and that this procedure allows improved detection of
gamma-H2AX in WBC.
Initially, the procedure included washing of the
nuclei after the antibody staining, by centrifugation.
This resulted in a high proportion of doublet nuclei,
and large aggregates that prevented reproducible quanti-
ﬁcation of the FITC signal. Aggregation was avoided
when washing of the nuclei was omitted, but resulted in
a slightly increased background signal from WBC not
treated with CLM.
To further optimize the gamma-H2AX-method, we
undertook a survey of diﬀerent blocking agents and
staining procedures (Table 1). It was found that addition
of sonicated chromosomal DNA, with a medium size of
100–300bp, resulted in a reduction of the background
signal, as well as an increase of the signal in CLM-treated
cells (Figure 1B). The signal enhancement was less
pronounced using similar amounts of a double-stranded
32-bp oligonucleotide (data not shown). We also found
that high molecular weight DNA induced aggregation of
nuclei, resulting in non-reproducible ﬂow cytometry
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FITC signal increased with longer staining times up to 3h,
but prolonged staining up to 20h did not result in further
enhancement of the signal. Storage of CLM-treated blood
on ice for 30h before gamma-H2AX staining resulted in
less than 15% reduction of the gamma-H2AX signal
indicating that it is possible to store blood samples for
one day without loss of the gamma-H2AX signal.
CLM-treated WBC could be stored at  808C in PBS for
extended periods of time without loss of the gamma-
H2AX signal. In contrast, if CLM-treated blood samples
were frozen using several diﬀerent protocols, WBC or
lymphocytes retrieved from the frozen sample consistently
lost the gamma-H2AX signal. Therefore, if the blood
samples were not analyzed directly the sample could be
stored on ice for 24h, or lymphocytes prepared and stored
at  808C. The gamma-H2AX signal increased linearly
with CLM concentrations from 0.5 to 10nM, but started
to level out at 50nM (Figure 1C). The same cells were
analyzed with the alkaline comet assay (Figure 1C).
The result indicated that the gamma-H2AX method was
able to detect 100-fold lower levels of CLM-induced
DNA damage compared to the alkaline comet assay.
FITC signal
100 101 102
AC
D
B
Figure 1. Optimization of gamma-H2AX measurement in WBC by ﬂow cytometry. (A) Staining for gamma-H2AX does not require ﬁxation. WBC
was prepared from blood, not treated (No CLM), or treated with 160nM CLM (CLM), and not ﬁxed (No Fix), ﬁxed with ethanol (EtOH), or ﬁxed
with PFA before staining for gamma-H2AX with a FITC-labeled gamma-H2AX antibody. The mean FITC intensity was measured by ﬂow
cytometry. (B) DNA in the blocking solution enhances the gamma-H2AX signal. Flow cytometry plot of WBC prepared from blood not treated
(left), or treated with 160nM of CLM (right). The cells were stained for gamma-H2AX in Block 8 without (black), or with (gray) of 0.25mg/ml
sonicated chromosomal DNA, and the FITC signal was measured by ﬂow cytometry. (C) The gamma-H2AX signal increases linearly with DNA
damage. Lymphocytes were prepared from blood samples treated with 0.5, 1.5, 3, 6, 12, 25, 50, 100 or 200nM CLM for 30min, and analyzed for
gamma-H2AX and by the comet assay. Error bars represent variation among duplicate samples. (D) Blood pooled from 4 donors was irradiated with
gamma radiation on ice before incubation at 378C for 30min. Lymphocytes were prepared and the resulting gamma-H2AX signal determined.
Table 1. Diﬀerent ingredients eﬀect on gamma-H2AX staining
Ingredient Fold change in gamma-H2AX-signal
Phosphatase inhibitors 2.01
DNA 0.25g/l 1.87
8% Mouse serum 1.71
16% Mouse serum 1.01
gamma-H2AX ab 0.4mg/l 0.95
gamma-H2AX ab 0.3mg/l 0.65
gamma-H2AX ab 0.2mg/l 0.50
Okadaic acid 1mg/l 1.05
Protease inhibitors 0.92
MgCl2 5Mm 0.70
PFA ﬁxation 0.30
EtOH ﬁxation 0.21
DNaseI 0.2g/lþMgCl2 5mM 0.25
0.03% Triton X100 0.15
polylysine 0.1g/l 0.07
PEG 6000 6% 0.02
Protease inhibitors were 1mM phenylmethylsulfonyl ﬂuoride, 1mM
benzamidine-HCl, 1mg/ml leupeptin, 1mg/ml pepstatin A. Fold change
in gamma-H2AX was calculated by dividing the mean FITC signal
obtained in WBC, prepared from blood treated with 160nM CLM,
and stained in block 8, with or without the indicated alteration.
For example, phosphatase inhibitors and DNA resulted in a 2-fold
increase in the gamma-H2AX signal, whereas PFA ﬁxation resulted in
a 3-fold decrease of the gamma-H2AX signal.
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doses of ionizing radiation showed that the gamma-H2AX
signal was detectable at doses as low as 0,1Gy
(Figure 1D). The gamma-H2AX assay was reproducible,
and double samples varied typically with a CV below 5%.
The Block 8 solution was stable for at least 2 months
at þ48C. We conclude that measurement of the gamma-
H2AX signal in non-ﬁxed cells by FACS analysis is
a convenient, sensitive and reproducible way to measure
the DSB response in patient cells.
The FITC signalin response toDSBs specifically
measures gamma-H2AX
To examine if the FITC signal speciﬁcally reﬂected
accumulation of gamma-H2AX, mouse embryonic ﬁbro-
blasts (MEFs) with (H2AXþ/þ) or without (H2AX / )
H2AX expression (27) were treated in growth medium
with various concentrations of CLM to induce DSBs. We
observed that cleavage of cellular DNA by CLM was
almost 10 times more eﬃcient in growth medium
compared to when CLM was added to blood (data not
shown), possibly because CLM binds or is partly
inactivated by some blood component. Therefore the
gamma-H2AX signal was more pronounced at low CLM
concentrations in this experiment compared to when CLM
was added directly to blood (compare Figure 1C and
Figure 2). In the absence of CLM, the gamma-H2AX
signal was the same in both H2AX /  and H2AXþ/þ
cells and not signiﬁcantly higher compared to undam-
aged lymphocytes prepared from blood. As expected,
H2AXþ/þ MEFs showed a CLM-dose-dependent
increase of the FITC signal. In contrast, the H2AX / 
MEFs failed to show any FITC signal over background
even at doses of CLM that produced maximal FITC signal
in H2AXþ/þ cells (Figure 2). We therefore conclude that
our ﬂow-cytometry protocol speciﬁcally measures gamma-
H2AX accumulation.
The gamma-H2AX signal in differentblood cells
Next, we wanted to examine the gamma-H2AX signal in
diﬀerent blood cells. To this end, blood from a healthy
subject was treated with diﬀerent concentrations of CLM
in vitro. WBC was prepared, and neutrophils, monocytes,
T-lymphocytes and B-lymphocytes were separated by ﬂow
cytometry sorting. The cells were then stained for gamma-
H2AX (Figure 3) or analyzed with the comet assay,
to measure independently the levels of CLM-induced
DNA strand breaks. The gamma-H2AX signal was
present in all nucleated cell types examined. The gamma-
H2AX signal and the comet signal were lower in
neutrophils compared to monocytes and T-lymphocytes.
The gamma-H2AX signal in the unsorted WBC showed
an intermediate response, compared to neutrophils and
lymphocytes, reﬂecting the fact that neutrophils consti-
tuted approximately 50% of the WBC population in this
blood sample. B-lymphocytes showed 3 times higher level
of gamma-H2AX signal, despite having similar amount of
DNA damage as measured by the alkaline comet assay.
However, B-lymphocytes constituted less than 5% of the
WBC (data not shown) and therefore contributed little
to the signal from unsorted WBC. Therefore, the majority
of unsorted WBC shows a homogenous gamma-H2AX
induction. It is therefore possible to measure the DSB
response in unsorted WBC cells.
Interindividual variation of thegamma-H2AX
signalin response toDSB inducing agents
Next, we wanted to know if our gamma-H2AX assay
could be used to measure the gamma-H2AX signal in
Figure 2. The gamma-H2AX assay speciﬁcally detects CLM-induced
H2AX phosphorylation. Non-transformed mouse embryonic
ﬁbroblasts (MEFs) expressing H2AX (H2AXþ/þ) and MEFs lacking
H2AX expression (H2AX / ) were treated with diﬀerent CLM
concentrations in growth medium for 30min before analysis with the
gamma-H2AX assay.
Figure 3. Gamma-H2AX signal in diﬀerent blood cell populations.
WBC was prepared from blood treated with 40nM CLM, or 200nM
CLM. The cells were stained with diﬀerent surface markers, and
neutrophils (NEU), T-lymphocytes (LYM-T), monocytes (MON) and
B-lymphocytes (LYM-B) were puriﬁed by ﬂow cytometry sorting.
Sorted cells treated with 40nM CLM were stained for gamma-H2AX
(black bars). Sorted cells from the 200nM CLM treatment were
subjected to the comet assay, to measure the levels of total DNA strand
breaks. The comet assay results were analyzed using visual scoring.
Error bars represent variation among duplicate samples.
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ten patients admitted to the hospital for medical reasons
unrelated to cancer, and treated this blood in vitro with
two diﬀerent concentrations of CLM. WBC cells were
prepared and stained for gamma-H2AX (Figure 4A),
or prepared for DNA strand break measurements, using
the comet assay (Table 2). The results showed that the
gamma-H2AX signal varied almost 2-fold among the
highest and the lowest values, with a CV of 18%. There
was no correlation between the level of strand breaks, as
measured by the comet assay and the gamma-H2AX
signal (R
2¼0.2). In addition, we failed to ﬁnd any
A
B
Age (years)
CLM (nM)
Figure 4. The CLM-induced gamma-H2AX signal in WBC shows
signiﬁcant variation among individuals. (A) Measurement of the
gamma-H2AX signal in ten patients. Blood samples from ten patients
were treated in duplicate with 0, 30 or 100nM CLM. WBC were
prepared, and the resulting gamma-H2AX signal was measured by ﬂow
cytometry. (B) No correlation between age and the gamma-H2AX
signal. Blood samples from nine patients, with the age between 1 and
16 years, from a pediatric primary health care center, and blood
samples from eleven patients 77–89 years old, admitted to the hospital,
were treated in duplicate with 40nM CLM. WBC were prepared,
and the gamma-H2AX signal measured. A horizontal line indicates
the mean gamma-H2AX signal in each age group. Error bars represent
the diﬀerence in mean FITC signal intensity between double samples.
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and other parameters analyzed (Table 2). We also
analyzed the gamma-H2AX signal after in vitro CLM
treatment of blood samples from nine children (1–16
years), and eleven patients around eighty years old (77–89
years). There was no statistical diﬀerence in the gamma-
H2AX signal between these age groups (Figure 4B).
We also wanted to use IR to examine the interindividual
diﬀerence in gamma-H2AX response. Therefore, to ﬁnd
the dynamic range of the gamma-H2AX signal in response
to IR, we irradiated blood from one healthy subject with
diﬀerent doses of gamma radiation. The blood were kept
on ice, or incubated at 378C for diﬀerent times.
Lymphocytes were prepared and the resulting gamma-
H2AX signal measured. The results indicated that there
was a linear increase of the gamma-H2AX signal up
to 20Gy and that incubation for 30min at 378C gave an
optimal gamma-H2AX signal (Figure 5A). We also noted
that there was a reduction of the gamma-H2AX signal
after 4.5h incubation at 378C that was more pronounced
at low doses of IR, probably reﬂecting repair of
DSBs (36). Essentially no reduction of gamma-H2AX
was observed in granulocytes from the same blood
samples (data not shown), indicating that measurement
of DSB repair by gamma-H2AX removal must be done on
puriﬁed lymphocytes. Based on this information we
decided to irradiate blood from 20 patients with 8Gy,
a dose expected to be well within the linear dose range
with respect to the gamma-H2AX signal. Lymphocytes
were prepared directly after irradiation and analyzed
by the comet assay to determine the initial amount of
DNA damage (Table 3). The rest of the irradiated blood
was divided into two samples. One sample was incubated
for 30min and the other for 5h at 378C before lymphocyte
preparation and analysis with the gamma-H2AX assay
and the comet assay. We observed a 2-fold diﬀerence in
gamma-H2AX signal among the patients (Figure 5B). The
gamma-H2AX signal correlated poorly with all blood
parameters analyzed (Table 3).
Previous reports indicate that the rate of gamma-H2AX
removal correlates with DSB repair capacity (37), and that
this correlation is best observed at doses of IR around
2Gy (36). Although the IR dose in this experiment was
optimized to observe diﬀerences in the initial gamma-
H2AX response we used gamma-H2AX signal reduction
after 5h as a marker for DSB repair in the patients.
We found that the reduction in gamma-H2AX signal
after 5h varied between 59 and 71% among the patients
(Figure 5B). This indicated that the variation of DSB
repair capacity among the patients was in the order of
0.3-fold, compared to the 2-fold variation in initial
gamma-H2AX signal. However, similar experiments
using lower doses of IR must be performed to more
accurately measure DSB repair rates.
In conclusion, we ﬁnd that our ﬂow-cytometry-based
method conveniently allows measurement of the gamma-
H2AX signal in routine patient samples and reveals
a marked variation in the gamma-H2AX signal in blood
cells exposed to CLM or IR among patients.
DISCUSSION
Gamma-H2AX (gH2AX) has been shown to be a sensitive
indicator of DSBs produced by IR, drugs or physiological
processes, such as V(D)J-recombination (11). Using ﬂow
cytometry, we have optimized a method for detecting
gamma-H2AX in human blood cells. Since the DNA
damage induced signal from the FITC-labeled mono-
clonal antibody was absent in H2AX /  cells we
A
B
Figure 5. The gamma-H2AX signal in blood lymphocytes irradiated
with gamma radiation. (A) Measurement of IR-induced DNA damage
by the gamma-H2AX assay and the comet assay in lymphocytes. Blood
samples from a healthy subject were irradiated on ice with 0, 6, 20 or
60Gy of gamma radiation. Lymphocytes were prepared from a sample
of each irradiated blood sample and analyzed by the comet assay.
The irradiated blood samples were incubated for 0.5 or 4.5h at 378C
to allow H2AX phosphorylation. Lymphocytes were prepared
and analyzed with the gamma-H2AX assay. (B) The IR-induced
gamma-H2AX signal in lymphocytes shows signiﬁcant variation among
individuals. Blood from 20 patients were irradiated on ice with 8Gy
of gamma radiation and incubated for 0, 0.5 or 5h at 378C before
preparation of lymphocytes. The lymphocytes were analyzed by
the gamma-H2AX assay and by the comet assay. Error bars represent
the diﬀerence in mean FITC signal intensity between double samples.
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H2AX accumulation. Previous protocols for ﬂow-
cytometry measurement of gamma-H2AX have used
ﬁxed cells. We found that ﬁxation could be omitted, and
this signiﬁcantly improved the gamma-H2AX staining
intensity in WBC from patient blood samples. It is
possible that less compact chromatin in non-ﬁxed nuclei
result in improved antigen presentation. The gamma-
H2AX signal was linearly correlated with the level of
strand breaks and allowed detection of strand breaks
induced by CLM hundred times below the detection limit
for the comet assay. The comet assay is a sensitive method
that measures DNA strand breaks in individual cells.
This assay is capable of detecting strand breaks in
cells exposed to 1–2Gy, close to the mean lethal dose.
This shows that gamma-H2AX measurement on non-ﬁxed
cells is a very sensitive and simple way to measure
DSB levels in human subjects.
We also found that blood samples could be stored on
ice for extended periods of time without loss of the
gamma-H2AX signal, which is important in the clinical
setting where blood samples often are analyzed several
hours to a day after they have been withdrawn.
In addition, puriﬁed WBC or lymphocytes could be
stored at  808C for long periods of time without loss
of the gamma-H2AX signal.
Gamma-H2AX can also be measured by immuno-
histochemistry. By counting gamma-H2AX- foci, it is
possible to measure very low levels of DNA damage that
are inﬂicted during routine X-ray examinations (38).
A comparison of our ﬂow-cytometry method with
published data indicates that foci counting can detect
close to ten times lower doses of IR (28). The gamma-
H2AX foci method is, however, labor intensive, and will
be hard to apply in clinical practice. In contrast, our ﬂow
cytometry method is currently in a format that can be used
in routine ﬂow cytometry analysis of patient samples.
Although our ﬂow-cytometry method was optimized for
cells obtained from patient blood, we have found that
gamma-H2AX measurement in non-ﬁxed cell lines result
in lower background in non-damaged cells and higher
gamma-H2AX signal in CLM-treated cells. Cell types that
have been tested in this regard include primary MEFs
(Figure 2), HeLa cells, primary human chondrocytes,
EBV-transformed B-cells, glioma cells (Mo59K, Mo59J)
and melanocytes (G361) (data not shown). Our method
can therefore be used to measure gamma-H2AX induction
in both clinical samples and in cells grown in the lab.
WBC prepared from normal individuals does not
contain any cells in S- or G2-phase. We have therefore
not included any measure of DNA content in the current
form of the assay. It is however possible to add
DNA-binding, ﬂuorescent drugs, like Hoecht 33352
that does not overlap with FITC emission spectrum (34).
However, eﬃcient Hoecht 33352 detection requires
expensive UV lasers, that most often are not available in
routine ﬂow cytometry machines. We found that the
ﬂuorescence signal from most other DNA dyes, including
propidium iodide, partly overlap with the FITC signal
from the gamma-H2AX-antibody and decreases the
sensitivity of the assay especially at low levels of DNA
damage. During the assay development, we observed that
Table 3. Analysis of the gamma-H2AX signal in response to IR in twenty patients
Patient Age Sex gH2AX after 0.5h
at 378C
gH2AX after
5h at 378C
Comet
(visual score)
WBC (10
9/l) NEU% LYM% MON% PLT (10
9/l) HGB (g/l) TSB repair
(% of initial
damage)
1 41 M 202þ/ 48 8 þ/ 5 230 7.49 51.3 37.7 6.6 198 162 99.8
2 52 M 291þ/ 3 107þ/ 1 200 5.84 71.4 16 10.3 150 135 99.3
3 53 F 311þ/ 10 120þ/ 2 248 9.69 76.6 15.2 10.3 331 110 99.9
4 10 M 270þ/ 19 0 þ/ 3 227 2.31 17.4 36.8 36.5 326 136 99.7
5 67 M 297þ/ 8 102þ/ 0 208 5.1 63.5 23.1 9.7 355 119 100
6 20 F 352þ/ 0 136þ/ 1 193 2.69 62.1 27.4 7.7 62.2 104 100
7 77 M 303þ/ 49 7 þ/ 2 164 13.9 84.9 6.3 7.8 150 131 100
8 32 M 250þ/ 15 84þ/ 0 80 14 79.3 8 11.4 171 166 99.9
9 73 M 323þ/ 3 110þ/ 3 132 10.8 79.9 13.9 4.2 384 98 99.9
10 77 M 326þ/ 16 113þ/ 2 208 11.7 84.2 9.1 6.3 275 89 100
11 57 F 288þ/ 17 104þ/ 6 230 10.5 55.7 31.2 11.9 81 134 100
12 45 M 297þ/ 2 105þ/ 1 173 6.31 55.5 28.7 8.8 239 107 100
13 58 F 321þ/ 6 113þ/ 1 125 9.01 70 17.2 11.2 393 108 100
14 32 M 257þ/ 28 6 þ/ 2 157 12.8 80.5 7.7 10.1 181 168 100
15 43 F 303þ/ 1 133þ/ 3 128 3.75 75.7 11.8 12.2 73.5 90.7 100
16 68 F 306þ/ 5 115þ/ 1 140 4.75 71.2 17.8 9.2 176 114 100
17 72 F 268þ/ 11 115þ/ 5 125 5.02 32.1 52 12.9 327 141 100
18 80 F 299þ/ 3 128þ/ 4 241 19.1 90.6 5.3 3.1 296 116 100
19 28 F 244þ/ 49 3 þ/ 1 159 2.61 70.5 7.6 21.7 79.2 85.3 100
20 23 F 324þ/ 4 136þ/ 1 231 6.38 80.1 11.3 8.2 32.3 89.9 99.9
R
2 0.02 1 0.2635 0.0024 0.005 0.0149 0.0041 0.1868 0.002 0.272 0.0507
gH2AX after 0.5 and 5h indicates the mean FITC intensity obtained in lymphocytes after irradiation and incubation at the indicated times at 378C.
WBC indicates the white blood cell count. NEU%, LYM%, MON% indicates the percentage of neutrophils, lymphocytes or monocytes respectively.
In the diﬀerential count PLT indicates the platelet count. HGB indicates blood hemoglobin concentration. TSB indicates the percentage of the intitial
DNA damage remaining after 0.5h at 378C measured by the comet assay. R
2 indicates the linear coeﬃcient of determination between gH2AX signal
after 0.5h and the indicated parameter.
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to the FITC signal from blood cells was very low.
Therefore, we have not included any DNA dye in the
gamma-H2AX assay.
To validate that our method could be used to monitor
DSBs in patient cells, we used the gamma-H2AX assay to
examine the DSB signal in response to CLM or IR in
a small number of patients. We also measured the levels
of strand breaks in the same population of cells, using
the comet assay. The data indicated that there was a
signiﬁcant variation in the level of gamma-H2AX that
did not correlate with the DNA damage level measured
by the comet assay or patient age. We also failed to ﬁnd
any other routine blood parameter that correlated with
the gamma-H2AX signal. It is possible that our ﬁnding
represents an inherent diﬀerence in the gamma-H2AX
signal among humans. This could, for instance, be due to
diﬀerence in the number of gamma-H2AX foci formed at
a given DNA damage level. This would imply that the
eﬃciency by which the cell converts DSBs to gamma-
H2AX foci varies among individuals. We ﬁnd this
explanation unlikely since the number of gamma-H2AX
foci correlates well with the levels of DSBs measured
with electrophoretic techniques (28) or by decay of
125I incorporated in cellular DNA that produce DSBs
with 90% eﬃciency (29). A more likely possibility is that
the number of gamma-H2AX molecules produced per
DSB varies among individuals. If this latter scenario
were true, the interindividual variation of gamma-H2AX
accumulation would not be possible to detect using
gamma-H2AX foci counting since this method provides
no information about the brightness of each focus.
Regardless of the mechanism behind the gamma-H2AX
signal variation, it will be interesting to examine if this
phenomenon is linked to IR sensitivity (32–34) and
therefore could be used to, as a part of radiotherapy
planning, identify the most IR-sensitive patients (39).
Another interesting application of the gamma-H2AX
assay would be to measure the DSB response in cancer
patients undergoing treatment with DSB-inducing agents
like IR, doxorubicin, etoposide or CLM-linked antibodies
(gemtuzumab, ozogamicin). These drugs have a narrow
therapeutic window and display variable pharmaco-
kinetics. Therefore, the gamma-H2AX assay could allow
us to administer DSB-inducing drugs based on the
resulting DSB signal in the patient to allow individualized
cancer treatment.
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